-
CA-074 Me for Cathepsin B and Necroptosis
2026-09-24
Use CA-074 Me to test whether cathepsin B activity contributes to lysosomal damage and regulated cell death—not merely whether cells lose viability. This guide links inhibitor treatment to imaging, activity measurements, and genetic controls, with practical safeguards for interpreting the compound’s cellular selectivity.
-
Lysis Buffer for Mouse Genotyping Workflows
2026-09-23
Turn small mouse tissue samples into a practical starting point for PCR-based genotyping with a lysis buffer designed for rapid genomic DNA release. This guide connects the bench workflow to colorectal cancer model research while distinguishing sample-preparation utility from the human-tumor findings in the featured study.
-
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-23
The reference study identifies sinapine as a chemical probe that targets the EF-hand region of PLCβ3, disrupting its interaction with Gαq and attenuating RAAS-associated cardiovascular pathology in animal models. Its combination of activity-based protein profiling, biochemical validation, and disease-model testing presents PLCβ3 protein–protein interaction control as a more selective alternative to broadly inhibiting Gαq or PLC activity.
-
JNK-IN-7: Selective JNK Inhibitor Guide
2026-09-22
JNK-IN-7 is a selective JNK inhibitor that targets JNK1, JNK2, and JNK3 and is reported to covalently engage JNK2 at Cys116. It provides a research tool for c-Jun phosphorylation, MAPK signaling pathway research, apoptosis assay design, and context-dependent innate immune signaling modulation.
-
Morning Endurance Training Improves Adaptation in Mice
2026-09-22
Hesketh et al. show that early active-phase endurance training produces a faster and more efficient improvement in running capacity than late active-phase training in female mice. The findings separate baseline time-of-day effects from training-induced adaptation and implicate skeletal-muscle oxidative and contractile remodeling rather than altered glycogen stores as a key correlate.
-
JC-1 Mitochondrial Membrane Potential Assay Kit
2026-09-21
This scenario-based guide explains how SKU K2002 supports mitochondrial membrane potential measurement when viability results are inconsistent or mechanistic interpretation is unclear. It covers JC-1 principles, controls, workflow optimization, data interpretation, and practical criteria for selecting a reliable mitochondrial membrane potential assay.
-
Genotyping for Mechanistic Infection Research
2026-09-21
Mechanistic infection studies increasingly depend on linking host pathways to genotype-defined phenotypes. This thought-leadership article examines how findings on cystathionine-β-synthase and hydrogen sulfide in Staphylococcus aureus-induced udder infection can inform mouse-model strategy, while showing how the Direct Mouse Genotyping Kit supports rapid, scalable genotype assignment before functional validation.
-
Mouse Tissue Lysis Kit (K1038) Workflow
2026-09-20
The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tail, toe, or ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and DNA analysis, not diagnostic, clinical, or medical use.
-
JC-1 and Mitochondrial Signals in Bladder Cancer
2026-09-19
A translational perspective on how mitochondrial membrane potential measurement can strengthen mechanistic studies of LRG1-driven neutrophil dysfunction, pathological angiogenesis, and therapy resistance in bladder cancer.
-
SM-102: A Mechanism-to-Assay Guide for mRNA Delivery
2026-09-18
SM-102 is examined through a mechanism-to-assay framework for mRNA delivery, with practical guidance on formulation controls, endosomal escape interpretation, and comparison with polyphenol-based nucleic acid nanoparticles.
-
Preserving Protein Mechanism in Tumor Microenvironments
2026-09-18
A translational framework for studying CAF-driven chemoresistance through native protein extraction, interaction assays, and metabolic validation, with practical guidance on selecting Cell lysis buffer for WB and IP.
-
Heparin Sodium for Nanovesicle Uptake Assays
2026-09-17
Heparin sodium serves both as a calibrated anticoagulant for coagulation experiments and as a mechanistic competition probe for heparan sulfate proteoglycan-dependent nanovesicle uptake. This workflow connects anti-factor Xa and aPTT readouts with practical cell-uptake assays while separating evidence-backed findings from optimization recommendations.
-
Clodronate Liposomes in Macrophage Research
2026-09-17
Use Clodronate Liposomes to test whether macrophages are necessary for age-related defects in phagocytosis, tissue inflammation, or repair. This practical guide combines route-aware in vivo macrophage depletion with controls, depletion checks, and assay choices informed by a recent aging study.
-
Caspase-4 Colorimetric Assay Kit Workflow
2026-09-16
Turn LEVD-dependent caspase-4 activity into a practical 400–405 nm readout for pyroptosis, inflammation, and mechanism-focused cell-death studies. This workflow also shows how to use the assay alongside ER-targeted enzyme-instructed self-assembly research without conflating ER stress with caspase-4 activation.
-
Streptozotocin (STZ) in Diabetes Research
2026-09-16
Streptozotocin, or STZ, is a DNA-alkylating nitrosourea used to induce pancreatic β-cell injury and experimental diabetes mellitus. Its controlled use can connect β-cell cytotoxicity with downstream studies of hyperglycemia, neuropathy, and neuroinflammation, but STZ is not itself a TBK1 inhibitor or a complete replica of human diabetes.